Intas Pharmaceuticals
Giridhar Venugopal Mandapati is an experienced professional in the pharmaceutical industry, currently serving as President and EVP of Emerging Markets & Business Development at Intas Pharmaceuticals. Previous roles include Senior Vice President of Strategic Marketing & Business Development and Vice President of the same division at Jubilant Life Sciences Ltd. Giridhar has also held key positions at Ranbaxy, including Director of Global Business Development & Acquisitions, Country Manager for Mexico, and Area Director for the Rest of Latin America. Early career experience includes brand management roles at Knoll Pharma and Alkem Laboratories Ltd. Educational qualifications include a Master’s in Marketing (MMM) from NMIMS and a Master of Pharmacy (M.Pharm) in Pharmaceutical Technology from L.M College of Pharmacy.
This person is not in the org chart
This person is not in any teams
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.